Revcovi Prices, Coupons and Patient Assistance Programs
Revcovi (elapegademase) is a member of the other immunostimulants drug class and is commonly used for Adenosine Deaminase Deficiency.
The cost for Revcovi intramuscular solution (1.6 mg/mL) is around $11,851 for a supply of 1.5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Revcovi price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Revcovi Coupons, Copay Cards and Rebates
Revcovi offers may be in the form of a printable coupon, rebate, savings or copay card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Revcovi Copay Program: Eligible commercially insured patients may pay as little as $0 per prescription; for additional information contact the program at 866-272-7078.
- Applies to:
- Number of uses:
- per prescription per calendar year
Form more information phone: 866-272-7078 or Visit website
Patient Assistance & Copay Programs for Revcovi
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
There are currently no Patient Assistance Programs that we know about for this drug.